Contact
Please use this form to send email to PR contact of this press release:
Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline 2024: Clinical Trials, FDA, EMA, and PMDA Approvals
TO:
Yash Bhardwaj
DelveInsight
+91 9650213330